Total net assets ($CAD):
$143.52 million

Asset allocation

Geographic allocation

Sector allocation

The top 15 holdings make up 90.16% of the Fund.
Top holdings Sector allocation (%)
Eli Lilly and Co Drugs 11.05%
AbbVie Inc Drugs 8.87%
Thermo Fisher Scientific Inc Healthcare Equipment 8.33%
UnitedHealth Group Inc Healthcare Services 8.02%
Merck & Co Inc Drugs 8.01%
AstraZeneca PLC Drugs 7.70%
DexCom Inc Healthcare Equipment 5.36%
Stryker Corp Healthcare Equipment 4.68%
Intuitive Surgical Inc Healthcare Equipment 4.62%
Gilead Sciences Inc Drugs 4.50%
Boston Scientific Corp Healthcare Equipment 4.30%
Danaher Corp Healthcare Equipment 4.20%
Anthem Inc Healthcare Services 3.99%
IQVIA Holdings Inc Drugs 3.36%
Lonza Group AG Drugs 3.17%